FDA approves HIV prophylactic

The US Food and Drug Administration (FDA) said Truvada (Gilead) appears to be safe and effective for HIV prevention.

It concluded that taking the pill daily could spare patients "infection with a serious and life-threatening illness that requires lifelong treatment".

A panel of FDA advisers is due to consider the review when it votes on whether Truvada should be approved as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse. The

Latest

Trending